J. Mogridge, K. Cunningham, D. B. Lacy, M. Mourez, and R. J. Collier, The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen, Proceedings of the National Academy of Sciences of the United States of America, vol.99, pp.7045-7053, 2002.

G. Vitale, R. Pellizzari, C. Recchi, G. Napolitani, M. Mock et al., Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages, Biochemical and biophysical research communications, vol.248, pp.706-717, 1998.

R. Hidi, B. B. Vargaftig, and L. Touqui, Increased synthesis and secretion of a 14-kDa phospholipase A2 by guinea pig alveolar macrophages. Dissociation from arachidonic acid liberation and modulation by dexamethasone, J Immunol, vol.151, pp.5613-5636, 1993.

R. Franson, P. Patriarca, and P. Elsbach, Phospholipid metabolism by phagocytic cells

, Phospholipases A2 associated with rabbit polymorphonuclear leukocyte granules, J Lipid Res, vol.15, pp.380-388, 1974.

M. Paya, M. C. Terencio, M. L. Ferrandiz, and M. J. Alcaraz, Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation, Br J Pharmacol, vol.117, pp.1773-1782, 1996.

J. Feuillard, S. Memet, B. Goudeau, A. Lilienbaum, R. Schmidt-ullrich et al., In vivo identification of lymphocyte subsets exhibiting transcriptionally active NF-kappaB/Rel complexes, Int Immunol, vol.12, pp.613-634, 2000.

Y. Z. Wu, S. Medjane, S. Chabot, F. S. Kubrusly, I. Raw et al., Surfactant protein-A and phosphatidylglycerol suppress type IIA phospholipase A2 synthesis via nuclear factor-kappaB, Am J Respir Crit Care Med, vol.168, pp.692-701, 2003.

V. Antonio, A. Brouillet, B. Janvier, C. Monne, G. Bereziat et al., Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors, The Biochemical journal, vol.368, pp.415-439, 2002.

M. Alaoui-el-azher, Y. Wu, N. Havet, A. Israel, A. Lilienbaum et al., Arachidonic acid differentially affects basal and lipopolysaccharide-induced sPLA(2)-IIA expression in alveolar macrophages through NF-kappaB and PPAR-gamma-dependent pathways, Molecular pharmacology, vol.61, pp.786-94, 2002.

M. Menschikowski, A. Hagelgans, E. Gussakovsky, H. Kostka, E. L. Paley et al., Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms, Neoplasia, vol.10, pp.279-86, 2008.

M. Menschikowski, A. Hagelgans, H. Kostka, G. Eisenhofer, and G. Siegert, Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells, Neoplasia, vol.10, pp.1195-203, 2008.

J. Lefort, M. Singer, D. Leduc, P. Renesto, M. A. Nahori et al., Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs, J Immunol, vol.161, pp.474-80, 1998.

M. Mock, A. Fouet, and . Anthrax, Annu Rev Microbiol, vol.55, pp.647-71, 2001.

R. E. Lincoln, D. R. Hodges, F. Klein, B. G. Mahlandt, W. I. Jones et al., Role of the lymphatics in the pathogenesis of anthrax, The Journal of infectious diseases, vol.115, pp.481-94, 1965.

P. C. Turnbull, Anthrax vaccines: past, present and future, Vaccine, vol.9, pp.533-542, 1991.

J. O. Gronroos, V. J. Laine, and T. J. Nevalainen, Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections, The Journal of infectious diseases, vol.185, pp.1767-72, 2002.

Y. Weinrauch, C. Abad, N. S. Liang, S. F. Lowry, and J. Weiss, Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2, The Journal of clinical investigation, vol.102, pp.633-641, 1998.

Y. Weinrauch, P. Elsbach, L. M. Madsen, A. Foreman, and J. Weiss, The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2, The Journal of clinical investigation, vol.97, pp.250-257, 1996.

D. K. Kim, T. Fukuda, B. T. Thompson, B. Cockrill, C. Hales et al., Bronchoalveolar lavage fluid phospholipase A2 activities are increased in human adult respiratory distress syndrome, The American journal of physiology, vol.269, pp.109-127, 1995.

G. Nakos, E. Kitsiouli, E. Hatzidaki, V. Koulouras, L. Touqui et al.,

, Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome, Crit Care Med, vol.33, pp.772-781, 2005.

L. Arbibe, D. Vial, I. Rosinski-chupin, N. Havet, M. Huerre et al., Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharideinduced type II phospholipase A2 synthesis, J Immunol, vol.159, pp.391-400, 1997.

H. L. Attalah, Y. Wu, M. Alaoui-el-azher, F. Thouron, K. Koumanov et al., Induction of type-IIA secretory phospholipase A2 in animal models of acute lung injury, Eur Respir J, vol.21, pp.1040-1045, 2003.

S. Furue, K. Kuwabara, K. Mikawa, K. Nishina, M. Shiga et al., Crucial role of group IIA phospholipase A(2) in oleic acid-induced acute lung injury in rabbits, Am J Respir Crit Care Med, vol.160, pp.1292-302, 1999.

L. Touqui and M. Alaoui-el-azher, Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases, Current molecular medicine, vol.1, pp.739-54, 2001.

A. P. Gimenez, Y. Z. Wu, M. Paya, C. Delclaux, L. Touqui et al., High bactericidal efficiency of type iia phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin, J Immunol, vol.173, pp.521-551, 2004.

A. Piris-gimenez, M. Paya, G. Lambeau, M. Chignard, M. Mock et al., In vivo protective role of human group IIa phospholipase A2 against experimental anthrax, J Immunol, vol.175, pp.6786-91, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00083712

B. Raymond, E. Batsche, F. Boutillon, Y. Z. Wu, D. Leduc et al., Anthrax lethal toxin impairs IL-8 expression in epithelial cells through inhibition of histone H3 modification, PLoS Pathog, vol.5, p.1000359, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00472920

B. Raymond, D. Leduc, L. Ravaux, L. Goffic, R. Candela et al., Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages, PLoS Pathog, vol.3, p.187, 2007.
URL : https://hal.archives-ouvertes.fr/pasteur-00317899

C. T. Baldari, F. Tonello, S. R. Paccani, and C. Montecucco, Anthrax toxins: A paradigm of bacterial immune suppression, Trends in immunology, vol.27, pp.434-474, 2006.

J. N. Tournier, A. Quesnel-hellmann, J. Mathieu, C. Montecucco, W. J. Tang et al., Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells, J Immunol, vol.174, pp.4934-4975, 2005.

P. Mikesell, B. E. Ivins, J. D. Ristroph, and T. M. Dreier, Evidence for plasmid-mediated toxin production in Bacillus anthracis, Infection and immunity, vol.39, pp.371-377, 1983.

B. D. Green, L. Battisti, T. M. Koehler, C. B. Thorne, and B. E. Ivins, Demonstration of a capsule plasmid in Bacillus anthracis, Infection and immunity, vol.49, pp.291-298, 1985.

R. Franson, P. Patriarca, and P. Elsbach, Phospholipid metabolism by phagocytic cells. Phospholipases A2 associated with rabbit polymorphonuclear leukocyte granules, J Lipid Res, vol.15, pp.380-388, 1974.